Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Expression level of UCMA as a candidate molecular target in osteoarthritis

Hamza Malik Okuyan, Ahmet Arslan, Yusuf Ziya Igci, Bulent Gogebakan, Nilufer Bilgic, Kubra Gunduz, Dilara Sonmez.




Abstract
Cited by 0 Articles

Aim: Osteoarthritis (OA) is a degenerative joint disorder that damages cartilage, synovium and subchondral bone, and there is yet no effective treatment for OA. The identification of novel therapeutic methods is crucially needed for better treatment of OA. Upper zone of growth plate and cartilage matrix associated (UCMA) was discovered as a chondrocyte specific protein in 2008, but its expression is solely not specific to cartilage tissue. Although UCMA is implicated in cartilage and bone metabolic processes, the molecular function of UCMA in OA is not elucidated yet. We aimed to examine the potential effect of UCMA in osteoblast metabolism associated with OA.
Materials and Methods: We created an in vitro OA model by inducing osteoblast cell line with IL-1β. The expression levels of 12 related genes were determined using the qRT-PCR method. The MMP1 and OPG expression levels in the supernatants of cells were detected with ELISA.
Results: We found that there was a dramatic increase in the levels of UCMA expression and other OA-related markers. We showed that IL-1β triggered the expression of main transcription factors playing a role during bone formation. MMP1 and OPG synthesis and secretions were increased in IL-1β induced-hFOB1.19 cell line significantly.
Conclusion: Our study, as the first one using the human osteoblast cell line, provides good evidence about the potential value of UCMA in the pathophysiology of OA and shows that UCMA can be a promising molecular target to develop therapeutic approaches for OA.

Key words: hFOB1.19; gene expression; inflammation; osteoarthritis; UCMA






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.